Pantoprazole for Injection IP 40 mg (PANTOSCOT-IV) is a prescription critical care injectable formulation supplied as lyophilized powder for IV use. Pantoprazole belongs to the proton pump inhibitor (PPI) class and is used under medical supervision for conditions where suppression of gastric acid secretion is required and intravenous therapy is appropriate.
PANTOSCOT-IV 40 mg is supplied with Sodium Chloride Injection IP 0.9% w/v, 10 ml, as shown in the product pack. The formulation is intended for intravenous administration by qualified healthcare professionals according to the prescribing information.
Ready product available – Order Now. Scotmed Care offers Pantoprazole Injection 40 mg for pharmaceutical distribution, institutional requirements, hospital supply and bulk business enquiries. Manufacturing support is available through a WHO-GMP certified plant, supporting quality-focused pharmaceutical supply requirements.
For Pantoprazole Injection 40 mg availability, bulk quantities, distribution or critical care injection manufacturing enquiries, contact Scotmed Care.
Prescription medicine. For IV use only. Use strictly under the supervision of a registered medical practitioner. Product availability and manufacturing certifications should be verified against current regulatory documentation.
Product Highlights
- Composition: Pantoprazole for Injection IP
- Strength: 40 mg
- Brand: PANTOSCOT-IV
- Dosage Form: Lyophilized Powder for Injection
- Route: IV use only
- Diluent shown: Sodium Chloride Injection IP 0.9% w/v, 10 ml
- Category: Proton Pump Inhibitor (PPI)
- Ready product available
- Bulk and institutional supply enquiries
- Critical care injectable portfolio
- Manufacturing support through WHO-GMP certified plant
- Prescription medicine for professional healthcare use
